The Current Ratio as of December 2025 (TTM) for Spyre Therapeutics, Inc. (SYRE) is 10.90

According to Spyre Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.90. This represents a change of 18.82% compared to the average of 9.18 of the last 4 quarters.

Spyre Therapeutics, Inc. (SYRE) Historical Current Ratio (quarterly & annually)

How has SYRE Current Ratio performed in the past?

The mean historical Current Ratio of Spyre Therapeutics, Inc. over the last ten years is 9.34. The current 10.90 Current Ratio has changed 11.57% with respect to the historical average. Over the past ten years (40 quarters), SYRE's Current Ratio was at its highest in in the June 2016 quarter at 22.88. The Current Ratio was at its lowest in in the June 2023 quarter at 1.03.

Spyre Therapeutics, Inc. (SYRE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Spyre Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Spyre Therapeutics, Inc. (SYRE) Average Current Ratio

How has SYRE Current Ratio performed in the past?

The current Current Ratio of Spyre Therapeutics, Inc. (SYRE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Spyre Therapeutics, Inc. (SYRE) Current Ratio vs. Peers

How is SYRE’s Current Ratio compared to its peers?

Spyre Therapeutics, Inc.’s Current Ratio is greater than Pharvaris N.V. (8.33), less than Immunome, Inc. (12.13), greater than Wave Life Sciences Ltd. (2.51), greater than Intellia Therapeutics, Inc. (6.21), greater than Zymeworks Inc. (6.94), less than Maze Therapeutics, Inc. (17.70), greater than AbCellera Biologics Inc. (10.10), less than Upstream Bio, Inc. (38.27), greater than Ardelyx, Inc. (4.41), less than Celldex Therapeutics, Inc. (19.67),

Build a custom stock screener for Spyre Therapeutics, Inc. (SYRE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spyre Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Spyre Therapeutics, Inc. (SYRE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Spyre Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.